Best Pharma Companies in India: Top 17 Pharmaceutical Companies Profiled (2026)

Quick answer first, then the detailed list — 17 of India's leading pharmaceutical companies, each with its headquarters, founding year and what it is actually known for. This is an editorial selection by VisitBest, not an official ranking: India has thousands of licensed drug manufacturers, and no government body publishes a single league table of them. Where a company publishes its own logo, we show it; where its website would not release one to us, the company is described in words instead — never illustrated with a stock picture or another firm's image.

India is routinely called the pharmacy of the world, and the description is earned. Indian factories supply affordable generic medicines and vaccines across Asia, Africa, Europe and the Americas, and the India Brand Equity Foundation (IBEF) describes India as the largest provider of generic medicines globally. Behind that headline sits a layered industry: a handful of very large, research-led companies that sell in the United States and Europe; a deep bench of mid-sized branded-generics firms that serve Indian doctors and patients; and thousands of smaller manufacturers and ingredient makers underneath them.

This guide profiles the top layer — the companies a patient, job-seeker, distributor or investor is most likely to meet. For city-level directories, see our guides to pharma companies in Hyderabad, pharma companies in Mumbai, pharma companies in Bangalore and pharma companies in Delhi. Company facts below — headquarters, founding years, therapy focus — are taken from the companies' own websites and reputable public sources, listed in the research note at the end. We have deliberately left out market-capitalisation league tables and revenue rankings: those move every quarter, and any list that prints them without a date is misleading you.

---

Quick Answer: Which Companies Should You Look at First?

For sheer scale and global reach, start with Sun Pharmaceutical, Cipla, Dr Reddy's and Aurobindo Pharma. For the ingredients layer that supplies the rest of the industry, look at Divi's Laboratories and Laurus Labs. For biotechnology and biosimilars, it is Biocon. For India's domestic branded market, study Torrent, Mankind, Alkem and Abbott India. And for focused specialists, read Ajanta Pharma, Ipca and JB Chemicals. The full profiles below explain what each company actually does.

How the Indian Pharma Industry Is Structured

Formulations first. Most large Indian companies earn their living from formulations — finished medicines such as tablets, capsules, injectables and inhalers. Within formulations there are two broad models. Branded generics, the dominant model inside India, are off-patent medicines sold under a company brand name and promoted to doctors. Unbranded or tender generics, and the US-style generics model, compete mainly on price and manufacturing cost in regulated export markets.

APIs underneath. Every formulation needs an active pharmaceutical ingredient (API) — the chemical that does the work. Companies such as Divi's and Laurus specialise in this layer, and most large formulators also make some of their own APIs to control cost and supply. India's API strength, rebuilt after supply shocks exposed dependence on imported intermediates, is a strategic part of the industry.

Biologics and vaccines. A smaller set of companies works with living cells rather than chemistry: biosimilars (highly similar copies of biologic medicines such as insulins and cancer antibodies) and vaccines. Biocon is the standard-bearer here. This layer needs the most capital and the deepest science, and it is where Indian firms compete most directly with global innovators.

Services around the edges. Contract development and manufacturing (CDMO/CRAMS) — making products for other companies — has become a major growth line for Divi's, Laurus, Aurobindo's subsidiaries and JB Chemicals, among others. Regulation ties it all together: the CDSCO and state drug controllers license and inspect Indian plants, while export plants are additionally inspected by the US FDA, European and other regulators whose markets they supply.

Best Pharma Companies in India — Quick Comparison

#	Company	Headquarters	Founded	Best known for
1	Sun Pharmaceutical Industries	Mumbai, Maharashtra	1983	Speciality + generics giant
2	Cipla	Mumbai, Maharashtra	1935	Respiratory and HIV medicines
3	Dr Reddy's Laboratories	Hyderabad, Telangana	1984	Generics, APIs, biosimilars
4	Divi's Laboratories	Hyderabad, Telangana	1990	APIs and custom synthesis
5	Zydus Lifesciences	Ahmedabad, Gujarat	1952	Generics, biologics, vaccines
6	Lupin	Mumbai, Maharashtra	1968	Generics; respiratory and chronic care
7	Aurobindo Pharma	Hyderabad, Telangana	1986	Generics at very large scale
8	Torrent Pharmaceuticals	Ahmedabad, Gujarat	1959	Branded generics, chronic therapies
9	Mankind Pharma	New Delhi, Delhi	1991	Affordable medicines + consumer brands
10	Alkem Laboratories	Mumbai, Maharashtra	1973	Branded generics, anti-infectives
11	Biocon	Bengaluru, Karnataka	1978	Biosimilars and insulins
12	Glenmark Pharmaceuticals	Mumbai, Maharashtra	1977	Respiratory, derma, oncology
13	Laurus Labs	Hyderabad, Telangana	2005	APIs and CDMO
14	Abbott India	Mumbai, Maharashtra	1910 (Abbott in India)	Established global brands (MNC arm)
15	Ipca Laboratories	Mumbai, Maharashtra	1949	Antimalarials, rheumatology, APIs
16	Ajanta Pharma	Mumbai, Maharashtra	1973	Speciality branded generics
17	JB Chemicals & Pharmaceuticals	Mumbai, Maharashtra	1976	Cardiology and gastro brands, CDMO

The order below is editorial — it roughly follows how widely each company is encountered across Indian and export markets, and is not a revenue or market-share ranking.

Detailed Profiles: 17 Leading Pharmaceutical Companies in India

1. Sun Pharmaceutical Industries

Headquarters: Mumbai, Maharashtra  |  Founded: 1983  |  Focus: Speciality medicines, generics and active pharmaceutical ingredients (APIs)

Quick highlights:

• Founded in 1983 by Dilip Shanghvi and grown, largely through acquisitions, into one of the world's largest generic pharmaceutical companies
• Runs a global speciality business alongside generics, with speciality brands in dermatology, ophthalmology and oncology
• Manufactures across India and overseas, supplying regulated markets including the United States

Sun Pharmaceutical Industries is the name most people meet first in Indian pharma. Started in 1983 by Dilip Shanghvi, it grew from a small formulations business into a global company by buying established brands and businesses, including Ranbaxy in 2014 — still one of the biggest deals in Indian pharmaceutical history. Today Sun works in three broad layers: a large generics business, an API business that supplies other manufacturers, and a growing speciality portfolio of patented and complex medicines sold in the United States and other regulated markets. For patients, its products cover everyday therapies from cardiology to psychiatry; for the industry, it is the benchmark Indian company for scale.

VisitBest recommendation: Start with Sun Pharma to understand the scale end of Indian pharma — a generics giant that is steadily shifting towards higher-value speciality medicines.

Headquarters	Mumbai, Maharashtra
Founded	1983
Focus	Speciality medicines, generics and active pharmaceutical ingredients (APIs)

2. Cipla

Headquarters: Mumbai, Maharashtra  |  Founded: 1935  |  Focus: Respiratory medicines, antiretrovirals and complex generics

Quick highlights:

• Founded in 1935 by Dr Khwaja Abdul Hamied as The Chemical, Industrial & Pharmaceutical Laboratories
• A world leader in respiratory medicine, known for its inhalers and nebulisation products
• Famous for offering an HIV/AIDS triple-therapy combination at a fraction of the prevailing price in 2001, which reset global expectations on access to antiretrovirals

Cipla is one of the oldest names in Indian pharmacy, founded in 1935 and headquartered in Mumbai. Two things define it. The first is respiratory care: Cipla built deep expertise in inhalers, spacers and respiratory medicines, a segment where device and drug must work together. The second is access. In 2001 Cipla offered a triple-drug antiretroviral combination for HIV/AIDS at under a dollar a day when the standard price was many times higher — a move widely credited with transforming treatment access in Africa. Today Cipla sells in India and in markets including the United States and South Africa, across respiratory, anti-retroviral, urology and acute care therapies.

VisitBest recommendation: Look at Cipla for respiratory care and for the clearest example of an Indian company built around affordable access to medicines.

Headquarters	Mumbai, Maharashtra
Founded	1935
Focus	Respiratory medicines, antiretrovirals and complex generics

3. Dr Reddy's Laboratories

Headquarters: Hyderabad, Telangana  |  Founded: 1984  |  Focus: Generics, APIs, biosimilars and speciality products

Quick highlights:

• Founded in 1984 in Hyderabad by Dr K. Anji Reddy, starting with active ingredients before moving into finished medicines
• One of the early Indian companies to build a serious biosimilars programme, alongside its generics and API businesses
• Strong presence in the United States, Russia and other emerging markets as well as India

Dr Reddy's Laboratories began in Hyderabad in 1984 as a maker of active pharmaceutical ingredients — the chemicals that make medicines work — and used that base to build a full formulations business. It is known for three things: a large generics portfolio sold in India, the United States, Russia and emerging markets; an API business that supplies other drug makers worldwide; and an early, sustained investment in biosimilars, the follow-on versions of complex biologic medicines. The company also runs a speciality and proprietary products segment. For anyone mapping the Hyderabad pharma cluster, Dr Reddy's is one of its anchor companies.

VisitBest recommendation: Shortlist Dr Reddy's for the classic Hyderabad model — API depth underneath a global generics and biosimilars business.

Headquarters	Hyderabad, Telangana
Founded	1984
Focus	Generics, APIs, biosimilars and speciality products

4. Divi's Laboratories

Headquarters: Hyderabad, Telangana  |  Founded: 1990  |  Focus: APIs, intermediates and custom synthesis for global innovator companies

Quick highlights:

• Founded in 1990 by Dr Murali K. Divi and based in Hyderabad
• Works mainly business-to-business: it manufactures active ingredients and intermediates, and performs custom synthesis for large innovator pharmaceutical companies
• Also produces nutraceutical ingredients such as carotenoids and vitamins

Divi's Laboratories is the company on this list that consumers rarely see but the industry depends on. Founded in 1990 and based in Hyderabad, Divi's manufactures active pharmaceutical ingredients and intermediates at very large scale, and offers custom synthesis — making specified compounds under contract for the global innovator companies that invented the medicines. Its plants around Visakhapatnam and Hyderabad are built for complex, high-volume chemistry, and it also makes nutraceutical ingredients. Because it sells to other pharmaceutical companies rather than to patients, Divi's success is measured in long-term supply relationships and manufacturing reliability rather than brands — a different, and very Indian, route to global scale.

VisitBest recommendation: Include Divi's to understand the API engine room of Indian pharma — the ingredients layer that much of the world's generic supply rests on.

Headquarters	Hyderabad, Telangana
Founded	1990
Focus	APIs, intermediates and custom synthesis for global innovator companies

5. Zydus Lifesciences

Headquarters: Ahmedabad, Gujarat  |  Founded: 1952  |  Focus: Generics, biologics, vaccines and novel therapies

Quick highlights:

• Traces its start to 1952, when Ramanbhai Patel set up the business that became Cadila Laboratories; the modern Zydus group took shape in the 1990s
• Works across generics, biologics and vaccines, and has developed its own novel medicines in India
• Headquartered in Ahmedabad, with a large generics business in the United States

Zydus Lifesciences carries one of the longest histories in Indian pharma: it began in 1952 as part of the Cadila Laboratories story in Ahmedabad, and the Zydus business emerged from the group's reorganisation in the 1990s. Today Zydus spans branded and generic formulations for India, a significant generics business in the United States, biologics, and vaccines. It is also one of the Indian companies to have taken an original discovery — its diabetes and metabolic research — through to an approved medicine in India. That breadth, from everyday generics to vaccines and new-drug research, makes Zydus a good single-company snapshot of where Indian pharma is heading.

VisitBest recommendation: Choose Zydus for breadth — generics, vaccines and biologics under one Ahmedabad roof, with genuine new-drug research behind it.

Headquarters	Ahmedabad, Gujarat
Founded	1952
Focus	Generics, biologics, vaccines and novel therapies

6. Lupin

Headquarters: Mumbai, Maharashtra  |  Founded: 1968  |  Focus: Generics and speciality medicines, with strength in respiratory and chronic therapies

Quick highlights:

• Founded in 1968 by Desh Bandhu Gupta, taking its name from the lupin flower
• A major supplier of generic medicines to the United States, alongside its India branded business
• Known strengths include respiratory, cardiovascular and anti-diabetic therapies, and a speciality women's-health business in the US

Lupin was founded in Mumbai in 1968 by Desh Bandhu Gupta and named after the lupin flower, chosen as a symbol of business that blooms in hard conditions. The company built its reputation first in anti-tuberculosis medicines and then across chronic therapies. Today Lupin runs two big engines: a branded formulations business in India across respiratory, cardiology, diabetes and other chronic segments, and an international generics business anchored in the United States, where it is one of the largest suppliers by prescriptions. It has also built a speciality business in women's health in the US and works on inhalation products, one of the harder generic categories to manufacture.

VisitBest recommendation: Look at Lupin for the chronic-therapy and inhalation story — and for how an Indian firm became a top-tier US generics supplier.

Headquarters	Mumbai, Maharashtra
Founded	1968
Focus	Generics and speciality medicines, with strength in respiratory and chronic therapies

7. Aurobindo Pharma

Headquarters: Hyderabad, Telangana  |  Founded: 1986  |  Focus: Generics and APIs at scale, including antiretrovirals and complex formulations

Quick highlights:

• Founded in 1986 in Hyderabad by P. V. Ramaprasad Reddy and K. Nityananda Reddy
• One of the highest-volume filers of generic drug applications in the United States, across oral solids, injectables and other dosage forms
• Supplies antiretroviral medicines for global HIV programmes alongside its regulated-market generics

Aurobindo Pharma, founded in Hyderabad in 1986, is Indian pharma's volume machine. It manufactures an unusually wide range of generic medicines — tablets, capsules, injectables, inhalers and more — supported by its own large API production, and files drug applications in the United States and Europe at a pace few rivals match. Aurobindo is also a significant supplier of antiretroviral medicines used in global HIV treatment programmes, and has expanded into biosimilars and vaccines through subsidiaries. Its model is breadth plus cost discipline: make many products, make them efficiently, and sell them in almost every major market. Few companies show the industrial scale of Indian generics better.

VisitBest recommendation: Study Aurobindo for manufacturing breadth — the widest generics catalogue on this list, from tablets to injectables.

Headquarters	Hyderabad, Telangana
Founded	1986
Focus	Generics and APIs at scale, including antiretrovirals and complex formulations

8. Torrent Pharmaceuticals

Headquarters: Ahmedabad, Gujarat  |  Founded: 1959  |  Focus: Branded generics with a chronic-therapy focus: cardiovascular, CNS, gastro and diabetes care

Quick highlights:

• Founded in 1959 by U. N. Mehta as Trinity Laboratories; renamed Torrent Pharmaceuticals in 1971
• Built its India business on chronic and sub-chronic therapies, especially cardiovascular and central nervous system medicines
• Also operates in the United States, Brazil and Germany, and owns long-standing Indian brands such as Shelcal

Torrent Pharmaceuticals began in Ahmedabad in 1959 as Trinity Laboratories, founded by U. N. Mehta, and took the Torrent name in 1971. Where several companies on this list chased the US generics market hardest, Torrent's centre of gravity is branded generics — named, doctor-promoted medicines — in India and a few chosen overseas markets such as Brazil and Germany. Its strongest ground is chronic therapy: cardiovascular, central nervous system, gastrointestinal and diabetes care, supplemented by vitamins and pain management. Household names like the calcium brand Shelcal came to Torrent through its acquisition of Elder's branded business. It is a study in focus: fewer markets, deeper therapy positions.

VisitBest recommendation: Pick Torrent for the branded-generics model — chronic-therapy depth in India rather than maximum geographic spread.

Headquarters	Ahmedabad, Gujarat
Founded	1959
Focus	Branded generics with a chronic-therapy focus: cardiovascular, CNS, gastro and diabetes care

9. Mankind Pharma

Headquarters: New Delhi, Delhi  |  Founded: 1991  |  Focus: Affordable medicines for mass-market India, plus consumer healthcare brands

Quick highlights:

• Incorporated in 1991 in New Delhi by brothers Ramesh C. Juneja and Rajeev Juneja, with operations building up from the mid-1990s
• Built its name on affordable pricing and reach into smaller towns and rural markets that larger firms served less intensively
• Owns household consumer brands including Manforce, Prega News, Unwanted-72 and Gas-O-Fast

Mankind Pharma took a different road from most companies here. Incorporated in 1991 in New Delhi and built up from the mid-1990s by brothers Ramesh C. Juneja and Rajeev Juneja, Mankind priced its medicines for the mass market and pushed distribution deep into smaller cities and towns. The strategy produced one of India's largest domestic pharma businesses by volume, spanning anti-infectives, cardiology, diabetes, dermatology and more. Alongside prescription medicines, Mankind owns some of India's most recognisable consumer healthcare brands — Manforce condoms, Prega News pregnancy kits, Unwanted-72 and Gas-O-Fast — which makes it the most consumer-facing company on this list.

VisitBest recommendation: Choose Mankind to see the mass-market India playbook — affordability, deep distribution and consumer brands beside prescription medicines.

Headquarters	New Delhi, Delhi
Founded	1991
Focus	Affordable medicines for mass-market India, plus consumer healthcare brands

10. Alkem Laboratories

Headquarters: Mumbai, Maharashtra  |  Founded: 1973  |  Focus: Branded generics, led by anti-infectives, with a growing international business

Quick highlights:

• Founded in 1973 in Mumbai by Samprada Singh
• Long known for anti-infective brands; its ranges include widely prescribed names such as Taxim and Clavam
• Sells in India and in international markets including the United States, with its own API and formulations manufacturing

Alkem Laboratories was founded in Mumbai in 1973 by Samprada Singh and grew into one of India's largest domestic pharmaceutical companies. Its historical strength is anti-infectives — antibiotics and related medicines — where brands such as Taxim and Clavam became fixtures of Indian prescribing; from that base it expanded across gastroenterology, pain management, vitamins and chronic segments. Alkem also built an international business, including a generics presence in the United States, and manufactures both APIs and finished formulations. It is less flamboyant than some peers, but its domestic prescription volumes place it firmly among the industry's leaders.

VisitBest recommendation: Include Alkem for the domestic prescription engine — anti-infective heritage broadened into a full chronic and acute portfolio.

Headquarters	Mumbai, Maharashtra
Founded	1973
Focus	Branded generics, led by anti-infectives, with a growing international business

11. Biocon

Headquarters: Bengaluru, Karnataka  |  Founded: 1978  |  Focus: Biologics and biosimilars, including insulins, plus generics and research services in the group

Quick highlights:

• Founded in 1978 in Bengaluru by Kiran Mazumdar-Shaw, starting out making industrial enzymes
• Pivoted into biopharmaceuticals and is known globally for biosimilars — including insulins and oncology and immunology biologics — through Biocon Biologics
• One of the few Indian companies whose core identity is biotechnology rather than chemistry-based generics

Biocon is the outlier on this list, in a productive way. Kiran Mazumdar-Shaw founded it in Bengaluru in 1978 to make industrial enzymes, and steered it into biopharmaceuticals as biotechnology matured. Through Biocon Biologics, the group develops and manufactures biosimilars — highly similar versions of complex biologic medicines — including insulins, and oncology and immunology products sold in the United States, Europe and emerging markets, alongside a generics business for small-molecule medicines and APIs. Making living-cell medicines at global quality standards is a different discipline from conventional generics, and Biocon is the Indian company most completely identified with it.

VisitBest recommendation: Shortlist Biocon for biotechnology — biosimilars and insulins are where Indian pharma meets its most complex science.

Headquarters	Bengaluru, Karnataka
Founded	1978
Focus	Biologics and biosimilars, including insulins, plus generics and research services in the group

12. Glenmark Pharmaceuticals

Headquarters: Mumbai, Maharashtra  |  Founded: 1977  |  Focus: Speciality, generics and OTC, with strength in respiratory, dermatology and oncology

Quick highlights:

• Founded in 1977 in Mumbai by Gracias Saldanha
• Combines a branded business in India and emerging markets with generics and an OTC segment
• Has a long record of new-drug research, with its innovation work now carried in a dedicated innovation company in the group

Glenmark Pharmaceuticals was founded in Mumbai in 1977 by Gracias Saldanha. Its business mixes three elements: branded medicines in India and other emerging markets, generic medicines for regulated markets including the United States, and over-the-counter products. Its therapy strengths are respiratory, dermatology and oncology. Glenmark has also, for decades, invested in discovering entirely new medicines — unusual among Indian generics-led companies — licensing candidate drugs to global partners and, more recently, housing its innovation pipeline in a dedicated group company. That combination of steady generics cash flows and genuine discovery ambition gives Glenmark a distinct profile among Indian mid-large pharma companies.

VisitBest recommendation: Look at Glenmark for the hybrid model — respiratory-led branded business plus one of India's longest-running new-drug research efforts.

Headquarters	Mumbai, Maharashtra
Founded	1977
Focus	Speciality, generics and OTC, with strength in respiratory, dermatology and oncology

13. Laurus Labs

Headquarters: Hyderabad, Telangana  |  Founded: 2005  |  Focus: APIs (including antiretrovirals), contract development and manufacturing (CDMO), and fermentation

Quick highlights:

• Founded in 2005 in Hyderabad by Dr Satyanarayana Chava — the youngest company in this list's top tier
• Became a major supplier of antiretroviral active ingredients used in HIV treatment worldwide
• Has expanded into contract development and manufacturing for global pharma and into fermentation-based products

Laurus Labs shows how quickly a focused Indian company can still rise. Founded in Hyderabad in 2005 by Dr Satyanarayana Chava, Laurus built its name making active pharmaceutical ingredients — above all the antiretroviral APIs that go into HIV medicines supplied across Africa and other regions. From that base it added finished formulations, a fast-growing contract development and manufacturing (CDMO) business that makes products for other companies, and fermentation capacity for speciality ingredients. Its plants are concentrated around Visakhapatnam and Hyderabad. In under two decades Laurus moved from start-up to a fixture of global HIV supply chains — the newest company here, and one of the most instructive.

VisitBest recommendation: Choose Laurus for the modern API-plus-CDMO story — and for proof that new entrants can still break into Indian pharma's top tier.

Headquarters	Hyderabad, Telangana
Founded	2005
Focus	APIs (including antiretrovirals), contract development and manufacturing (CDMO), and fermentation

14. Abbott India

Headquarters: Mumbai, Maharashtra  |  Founded: 1910 (Abbott in India)  |  Focus: Established (branded generic) medicines from Abbott's global portfolio, across women's health, gastroenterology, metabolic care and vaccines

Quick highlights:

• Abbott's own India site dates its presence in India to 1910, making it one of the oldest healthcare companies operating in the country
• Abbott India Limited is the publicly listed Indian arm of Abbott Laboratories of the United States, headquartered in Mumbai
• Markets a large portfolio of established medicine brands in India, in categories such as women's health, gastroenterology, cardiology and metabolic disorders

Abbott India is the multinational entry on this list. Abbott, the US healthcare group, says it has been present in India since 1910, and its listed Indian company, Abbott India Limited, is headquartered in Mumbai. Rather than competing mainly on new generics, Abbott India markets a deep bench of established, doctor-trusted brands across women's health, gastroenterology, cardiology, metabolic disorders, vaccines and primary care — the kind of long-lived brands that Indian households often know by name. It operates separately from Abbott's nutrition and diagnostics businesses in India. For readers comparing business models, Abbott India shows the MNC approach: global brands, local manufacturing and distribution, and a listed Indian subsidiary.

VisitBest recommendation: Include Abbott India for the multinational benchmark — established global brands run through a listed Indian subsidiary.

Headquarters	Mumbai, Maharashtra
Founded	1910 (Abbott in India)
Focus	Established (branded generic) medicines from Abbott's global portfolio, across women's health, gastroenterology, metabolic care and vaccines

15. Ipca Laboratories

Headquarters: Mumbai, Maharashtra  |  Founded: 1949  |  Focus: APIs and formulations, with recognised strength in antimalarials and rheumatology

Quick highlights:

• Founded in 1949 in Mumbai, beginning as The Indian Pharmaceutical Combine Associates
• Makes both active ingredients and finished formulations, exporting to markets worldwide
• Known therapy areas include antimalarials, cardiovascular, diabetes care and disease-modifying drugs for rheumatoid arthritis

Ipca Laboratories began in Mumbai in 1949 as The Indian Pharmaceutical Combine Associates — the source of the Ipca name. It is a fully integrated company: it synthesises its own active ingredients and turns them into finished formulations sold in India and exported widely. Ipca is particularly associated with antimalarial medicines, a category where Indian manufacturers supply much of the world's need, and with disease-modifying treatments for rheumatoid arthritis, alongside cardiovascular, diabetes and pain products. Less visible to consumers than some peers, Ipca's longevity — over 75 years — and its strength in specific therapy niches earn it a place in any honest survey of leading Indian pharma companies.

VisitBest recommendation: Pick Ipca for niche depth — antimalarials and rheumatology strength inside a fully integrated API-to-formulation business.

Headquarters	Mumbai, Maharashtra
Founded	1949
Focus	APIs and formulations, with recognised strength in antimalarials and rheumatology

16. Ajanta Pharma

Headquarters: Mumbai, Maharashtra  |  Founded: 1973  |  Focus: Speciality branded generics: ophthalmology, dermatology, cardiology and pain management

Quick highlights:

• Established in 1973 in Mumbai by Purushottam Agrawal
• Deliberately concentrates on a few speciality segments in India rather than covering every therapy area
• Sells branded generics across more than 30 countries in Africa, Asia and the CIS, plus a select generics portfolio in the United States

Ajanta Pharma, established in Mumbai in 1973, is the specialist's specialist on this list. In India it deliberately concentrates on four therapy areas — ophthalmology, dermatology, cardiology and pain management — building first-to-market branded generics within them rather than spreading across every segment. Internationally it sells branded generics in more than 30 emerging markets across Africa, Southeast Asia, West Asia and the CIS, runs institutional supply of antimalarials, and has built a select portfolio in the United States. Its manufacturing base spans several Indian plants plus Mauritius. Ajanta demonstrates that in Indian pharma, sharp focus can compete with sheer size.

VisitBest recommendation: Choose Ajanta for focused specialisation — proof that depth in a few therapy areas can rival the diversified giants.

Headquarters	Mumbai, Maharashtra
Founded	1973
Focus	Speciality branded generics: ophthalmology, dermatology, cardiology and pain management

17. JB Chemicals & Pharmaceuticals

Headquarters: Mumbai, Maharashtra  |  Founded: 1976  |  Focus: Branded medicines in cardiology and gastroenterology, plus contract manufacturing

Quick highlights:

• Founded in 1976 in Mumbai by J. B. Mody
• Home to long-standing Indian brands in cardiology and gastrointestinal care, including the Cilacar and Rantac ranges
• Also runs a contract manufacturing business, including medicated lozenges made for global customers

JB Chemicals & Pharmaceuticals — JB Pharma — was founded in Mumbai in 1976 by J. B. Mody. Its Indian business rests on durable, doctor-trusted brands, above all in cardiology (the Cilacar range for blood pressure) and gastroenterology (the Rantac range), together with products such as Metrogyl that have been prescribed in India for decades. In recent years JB has sharpened its focus on chronic therapies in India and grown a contract manufacturing arm that includes medicated lozenges produced for international customers. It is a mid-sized company by the standards of this list, included because its brands' longevity shows how value in Indian pharma often sits in trusted names, not only in scale.

VisitBest recommendation: Round out the list with JB Pharma for brand longevity — decades-old cardiology and gastro brands, plus a growing contract-manufacturing arm.

Headquarters	Mumbai, Maharashtra
Founded	1976
Focus	Branded medicines in cardiology and gastroenterology, plus contract manufacturing

Also Worth Knowing

The map is clustered. Hyderabad hosts Dr Reddy's, Aurobindo and Laurus and styles itself Pharma City; Mumbai anchors Sun Pharma, Cipla, Lupin, Alkem, Glenmark, Ipca, Ajanta, JB and Abbott India; Ahmedabad holds Zydus and Torrent; Bengaluru holds Biocon; Mankind is the Delhi entry. If you are job-hunting or scouting partners, those clusters are where the industry physically sits.

Why this list has no ranks. Rankings by revenue, market capitalisation and domestic sales give three different orders, and all three change with quarterly results and the rupee. What does not change quickly is what each company is built to do — which is why every profile above leads with focus, not position. If you need a dated financial ranking, use the companies' own annual reports or a named, dated source rather than an undated listicle.

Logos and descriptions. Thirteen companies here are shown with their own official logos, taken from their own websites. Four — Sun Pharmaceutical, Cipla, Zydus Lifesciences and Biocon — are described in words only, because their websites would not release a logo file to us (access blocks and unreachable servers, detailed in our research note). Rather than borrow an image from elsewhere, we left those four unillustrated.

FAQs

Which is the largest pharmaceutical company in India?

It depends on the measure. By global generics scale, Sun Pharmaceutical is usually placed at the top of Indian pharma; by domestic prescription sales, the order among Sun Pharma, Abbott India, Cipla, Mankind and Alkem shifts between audit periods. Because the answer changes with the measure and the quarter, this guide profiles the leading companies by what they do instead of crowning one permanent number one.

What is the difference between a generic and a branded generic?

A generic medicine contains the same active ingredient as an originally patented medicine, sold after patent expiry. In India most generics are sold under a company brand name — a branded generic — and promoted to doctors, whereas in the United States generics are usually sold under the chemical name and compete mainly on price.

What does an API company like Divi's or Laurus actually do?

API companies manufacture active pharmaceutical ingredients — the substances that make medicines work — and sell them to formulation companies, or manufacture custom compounds under contract for innovator firms. They rarely sell to patients, but much of the world's generic supply depends on them.

Which Indian companies work in biosimilars?

Biocon, through Biocon Biologics, is the most biosimilar-focused company on this list, with insulins and oncology and immunology products. Dr Reddy's and Zydus also run biologics and biosimilar programmes alongside their generics businesses.

How were these 17 companies selected?

Editorially, by VisitBest: sustained scale across Indian and export markets, a distinct and verifiable specialisation, and a public record — the company's own website and reputable sources — that supports every fact printed. It is a guide to the leading companies, not an official or exhaustive ranking, and strong regional or specialist firms outside this list exist in every state.

Conclusion

Indian pharma's strength is its variety: ingredient makers, generics exporters, branded domestic champions, biosimilar pioneers and one very old multinational arm, all operating at world scale. Use the comparison table to shortlist by what you need — a therapy area, a business model, a city cluster — then verify current details on the company's own website before you act on anything.

Research note: headquarters, founding years and focus areas were checked against each company's official website and reputable public sources (company profiles and reference works) in October 2026. Company logos are the companies' own, taken from their official websites and credited to them; four companies are description-only because their sites would not release a logo file — see the profile section note. Industry framing follows the India Brand Equity Foundation's published description of India as the largest provider of generic medicines globally. This is an editorial guide, not investment or medical advice.